Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2010
Date of Earliest Event: November 5, 2010
Context: The Company entered into a material definitive agreement to amend and restate its existing credit agreement and related guarantee and collateral agreements.
Key Financial Metrics and Debt Structure
This filing focuses on debt restructuring rather than operational financial performance. Specific revenue, profit, or cash flow figures are not provided in this document.
- Total Term Loan Balance: Approximately $6.0 billion (comprising $1.5 billion extended and $4.5 billion unchanged).
- Extended Term Loans: $1.5 billion.
- Unchanged Term Loans: Approximately $4.5 billion.
- Incremental Facility Capacity: Increased from $600 million to $1.0 billion.
- Senior Notes: 8.875% Senior Notes due 2015 (outstanding balance affects maturity date of extended loans).
Material Changes Versus Prior Period
The Amendment and Restatement Agreement dated November 5, 2010, introduced the following changes to the Credit Agreement originally dated July 25, 2007:
- Maturity Extension: The maturity date for $1.5 billion of term loans was extended by 2.5 years to January 25, 2017. This extension is subject to a condition: if more than $50 million of the 8.875% Senior Notes due 2015 remain outstanding on April 15, 2015, the maturity date reverts to April 15, 2015.
- Interest Rate Adjustment: Pricing on the extended term loans increased to LIBOR plus 350 basis points.
- Unchanged Maturity: The remaining $4.5 billion of term loans retains the original maturity date of July 25, 2014.
- Covenant Modifications: The agreement now permits the Borrower to incur or assume additional secured indebtedness on a pari passu basis, provided a required ratio of aggregate secured indebtedness to consolidated EBITDA is met.
- Guarantee Alignment: The Guarantee and Collateral Agreement was amended to conform to the new Credit Agreement terms.
Guidance, Outlook, and Risks
Management Commentary: The filing does not contain forward-looking guidance regarding revenue or earnings. The primary objective stated is the extension of debt maturity and increased flexibility for future indebtedness.
Risks and Contingencies:
- Senior Notes Condition: The extended maturity of the $1.5 billion term loan is contingent on the outstanding balance of the 8.875% Senior Notes due 2015. If the balance exceeds $50 million on April 15, 2015, the maturity accelerates to that date.
- Covenant Compliance: The ability to incur additional secured debt is subject to maintaining a specific ratio of aggregate secured indebtedness to consolidated EBITDA.
- Acceleration Events: The extended maturity is subject to customary acceleration events.
Key Facts for Investor Verification
- Verify the outstanding balance of the 8.875% Senior Notes due 2015 to determine if the $1.5 billion term loan maturity will remain at January 2017 or revert to April 2015.
- Review the consolidated EBITDA figures to assess the Company's capacity to incur additional secured indebtedness under the new covenant ratio.
- Confirm the total cost of debt impact resulting from the increase to LIBOR plus 350 basis points on the extended portion of the loan.
- Examine the full text of the Amendment and Restatement Agreement (Exhibit 10.1) for specific definitions of "customary acceleration events."